STOCK TITAN

Capital International Investors builds 6.8% passive stake in Align Technology (ALGN)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Capital International Investors, a division of Capital Research and Management Company and related investment management entities, reports a passive ownership stake in Align Technology, Inc. common stock. As of 12/31/2025, it is deemed to beneficially own 4,881,512 shares, representing 6.8% of the outstanding class.

The filing states that these securities were acquired and are held in the ordinary course of business, not for the purpose or effect of changing or influencing control of Align Technology. Capital International Investors has sole voting power over 4,843,331 shares and sole dispositive power over 4,881,512 shares.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



Capital International Investors
Signature:Jae Won Chung
Name/Title:Vice President and Senior Counsel II, Capital Research and Management Company
Date:02/12/2026

FAQ

What percentage of Align Technology (ALGN) does Capital International Investors own?

Capital International Investors reports beneficial ownership of 6.8% of Align Technology’s common stock. This corresponds to 4,881,512 shares out of 71,749,995 shares believed outstanding, indicating a significant institutional position but not a controlling interest.

How many Align Technology (ALGN) shares does Capital International Investors control?

Capital International Investors is deemed to beneficially own 4,881,512 Align Technology shares. It has sole voting power over 4,843,331 shares and sole dispositive power over 4,881,512 shares, reflecting substantial but non-controlling influence over the stock.

Is Capital International Investors’ stake in Align Technology (ALGN) intended to influence control?

The stake is certified as passive. Capital International Investors states the securities were acquired and are held in the ordinary course of business, not to change or influence control of Align Technology or to participate in any control-related transaction.

What type of filing is this Schedule 13G for Align Technology (ALGN)?

This is a Schedule 13G beneficial ownership filing by Capital International Investors. It discloses a passive institutional position exceeding 5% of Align Technology’s common stock, rather than an activist or control-seeking stake.

Who signed the Schedule 13G related to Align Technology (ALGN)?

The Schedule 13G was signed by Jae Won Chung, Vice President and Senior Counsel II of Capital Research and Management Company. The signatory certifies the accuracy of the ownership information and the passive investment intent language in the statement.

What is the reported Align Technology (ALGN) share count underlying the 6.8% stake?

Capital International Investors’ 6.8% beneficial ownership is based on 71,749,995 Align Technology shares believed to be outstanding. Its 4,881,512 shares represent this percentage of the issuer’s common stock as referenced in the ownership section.
Align Technology Inc

NASDAQ:ALGN

ALGN Rankings

ALGN Latest News

ALGN Latest SEC Filings

ALGN Stock Data

13.40B
68.97M
Medical Instruments & Supplies
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States
TEMPE